BNGO - Bionano Genomics Inc
1.21
0 0%
Share volume: 94,202
Last Updated: 04-24-2026
Measuring And Control Equipment/Lab Analytical Instruments:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$1.21
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-07-2024 | 11-14-2024 | 05-14-2025 | 08-14-2025 | 11-13-2025 | 03-23-2026 | |
| Assets | ||||||||
| Total Assets | 157.995 M | 129.364 M | 87.362 M | 78.414 M | 76.010 M | 79.062 M | 73.584 M | |
| Current Assets | 85.611 M | 60.568 M | 46.980 M | 44.929 M | 42.662 M | 48.800 M | 45.386 M | |
| Inventories | 19.587 M | 19.475 M | 14.323 M | 9.562 M | 8.633 M | 7.049 M | 5.448 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 12.561 M | 8.516 M | 3.160 M | 14.606 M | 12.876 M | 18.516 M | 16.279 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 15.759 M | 10.425 M | 8.794 M | 3.625 M | 3.562 M | 3.065 M | 2.990 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 25.279 M | 24.863 M | 19.995 M | 18.339 M | 17.264 M | 16.172 M | 14.847 M | |
| Other Assets | 47.105 M | 43.933 M | 20.387 M | 15.146 M | 16.084 M | 14.090 M | 13.351 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 157.995 M | 129.364 M | 87.362 M | 78.414 M | 76.010 M | 79.062 M | 73.584 M | |
| Total liabilities | 75.224 M | 49.027 M | 38.494 M | 30.226 M | 30.636 M | 29.263 M | 29.160 M | |
| Total current liabilities | 58.506 M | 37.175 M | 32.950 M | 26.408 M | 24.178 M | 22.977 M | 22.942 M | |
| Accounts Payable | 9.844 M | 8.734 M | 8.700 M | 6.562 M | 6.244 M | 5.990 M | 5.590 M | |
| Other liabilities | 16.580 M | 11.580 M | 5.281 M | 3.526 M | 6.215 M | 6.094 M | 5.969 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 16.580 M | 11.580 M | 5.281 M | 3.526 M | 6.215 M | 6.094 M | 5.969 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 82.771 M | 80.337 M | 48.868 M | 48.188 M | 45.374 M | 49.799 M | 44.424 M | |
| Common stock | 695.417 M | 709.194 M | 720.434 M | 744.501 M | 748.568 M | 761.480 M | 764.027 M | |
| Retained earnings | -612.630 M | -628.854 M | -673.100 M | -696.327 M | -703.184 M | -711.687 M | -719.620 M |